Novitium Pharma LLC has recalled 3,940 1000-count bottles of Digoxin (0.125 mg) tablets. The recall was initiated because the tablets may be cross-contaminated with another medication called mycophenolate mofetil. This affects lot number M23172A with an expiration date of 01/31/2025. If you are taking this medication, you should consult your doctor or pharmacist to determine if your supply is part of the recall.
The tablets may contain trace amounts of mycophenolate mofetil, an immunosuppressant drug. Unintended exposure to this contaminant could lead to serious health complications or interfere with the effectiveness of the heart medication being treated.
You have 2 options:
Quantity affected: 3,940 1000-count bottles
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.